Planned sale of 2,831 Bunge (NYSE: BG) shares disclosed

Rhea-AI Filing Summary

Bunge Ltd. filed notice of a planned stock sale under Rule 144. A shareholder intends to sell 2,831 shares of Bunge common stock through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $336,889. The shares were acquired on 02/11/2026 via a stock option exercise paid in cash. Bunge had 193,361,047 common shares outstanding at the time referenced in the notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2831	336889.00	193361047	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2026	Stock Option Exercise	Issuer			2831	02/11/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Bunge (BG) disclose in this Form 144 filing?

Bunge reports that a shareholder intends to sell 2,831 common shares under Rule 144. The sale will occur through Morgan Stanley Smith Barney on the NYSE, reflecting an aggregate market value of $336,889 at the time referenced.

How many Bunge (BG) shares are planned for sale and at what value?

The notice covers a planned sale of 2,831 Bunge common shares with an aggregate market value of $336,889. These figures come directly from the Rule 144 securities information section in the filing’s tabular disclosure.

How were the Bunge (BG) shares being sold under Rule 144 acquired?

The 2,831 Bunge common shares were acquired on 02/11/2026 through a stock option exercise from the issuer. The filing states that the exercise was paid in cash on the same date as the acquisition.

Through which broker will the Bunge (BG) shares be sold?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned Rule 144 sale. The broker’s address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, with the sale to occur on the NYSE.

What is the approximate sale date for the Bunge (BG) shares in this notice?

The approximate date of sale for the 2,831 Bunge common shares is 02/11/2026. This date appears in the securities information table, alongside the NYSE as the named securities exchange for the transaction.

How many Bunge (BG) shares were outstanding according to the Form 144?

The Rule 144 notice states that 193,361,047 Bunge common shares were outstanding. This figure is shown in the securities information table and serves as a baseline context for the planned 2,831-share sale.